NewAmsterdam Pharma Company N.V. (NAMS)

NASDAQ: NAMS · Real-Time Price · USD

36.53

-0.47 (-1.27%)

At close: Nov 4, 2025, 4:00 PM EST

35.60

-0.93 (-2.55%)

Pre-market: Nov 5, 2025, 8:00 AM EST

NAMS Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Nov '25 Nov 4, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	4,114	2,751	920	889	139	-
Market Cap Growth	140.18%	199.19%	3.44%	537.58%	-	-
Enterprise Value	3,331	2,329	501	796	144	-
Last Close Price	36.53	25.70	11.17	10.90	9.75	-
PS Ratio	61.20	60.38	65.26	8.66	-	-
PB Ratio	5.28	3.63	3.19	2.07	2.46	-
P/TBV Ratio	5.29	3.64	3.19	2.07	2.46	-
P/FCF Ratio	-	-	-	85.12	-	-
P/OCF Ratio	-	-	-	83.36	-	-
EV/Sales Ratio	52.05	51.12	35.56	7.75	-	-
EV/FCF Ratio	-	-	-	76.18	-	-
Debt / Equity Ratio	0	0.00	0	0	0.00	-3.26
Debt / FCF Ratio	-	-	-	0.01	-	-
Asset Turnover	0.10	0.08	0.03	0.38	-	-
Quick Ratio	20.79	8.00	6.86	13.03	5.81	0.61
Current Ratio	21.09	8.07	6.95	13.26	5.96	0.72
Return on Equity (ROE)	-28.43%	-46.20%	-49.25%	-9.30%	-159.01%	-
Return on Assets (ROA)	-17.12%	-18.19%	-27.70%	-0.81%	-55.71%	-
Return on Capital (ROIC)	-18.51%	-21.06%	-31.82%	-0.91%	-66.25%	-
Earnings Yield	-4.03%	-8.78%	-19.24%	-2.55%	-29.97%	-
FCF Yield	-3.02%	-5.79%	-15.36%	1.18%	-21.18%	-
Buyback Yield / Dilution	-23.19%	-14.84%	-333.20%	-72.75%	-119.58%	-

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q